| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 24 | 2020 | 1210 | 3.150 |
Why?
|
| Retinal Vessels | 15 | 2020 | 772 | 1.860 |
Why?
|
| Diabetes Mellitus, Experimental | 11 | 2020 | 1116 | 1.530 |
Why?
|
| Retina | 16 | 2009 | 2616 | 1.050 |
Why?
|
| Retinal Artery | 2 | 2016 | 111 | 0.870 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 2007 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2016 | 3336 | 0.600 |
Why?
|
| Monocytes | 2 | 2020 | 2596 | 0.590 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2016 | 1504 | 0.580 |
Why?
|
| Imidazolidines | 3 | 2009 | 39 | 0.560 |
Why?
|
| Sorbitol | 2 | 2007 | 59 | 0.550 |
Why?
|
| Fibronectins | 10 | 1997 | 726 | 0.540 |
Why?
|
| Pericytes | 4 | 2004 | 292 | 0.530 |
Why?
|
| Glucose | 10 | 2007 | 4397 | 0.470 |
Why?
|
| Endothelium, Vascular | 10 | 2002 | 4456 | 0.430 |
Why?
|
| Aldehyde Reductase | 3 | 2007 | 65 | 0.430 |
Why?
|
| Apoptosis | 9 | 2017 | 9727 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2002 | 1434 | 0.370 |
Why?
|
| Capillaries | 7 | 2017 | 773 | 0.340 |
Why?
|
| Galactosemias | 2 | 2000 | 125 | 0.300 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2016 | 242 | 0.300 |
Why?
|
| RNA, Messenger | 17 | 2001 | 13033 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2017 | 8301 | 0.270 |
Why?
|
| Posture | 1 | 2010 | 958 | 0.270 |
Why?
|
| Retinopathy of Prematurity | 1 | 2010 | 421 | 0.260 |
Why?
|
| Endothelial Cells | 3 | 2017 | 3479 | 0.260 |
Why?
|
| Pyridazines | 1 | 2006 | 202 | 0.250 |
Why?
|
| Fructose | 1 | 2007 | 288 | 0.250 |
Why?
|
| Collagen | 6 | 1997 | 2689 | 0.240 |
Why?
|
| Diabetes Mellitus | 5 | 2006 | 5751 | 0.240 |
Why?
|
| NF-kappa B | 2 | 2002 | 2499 | 0.220 |
Why?
|
| Complement Inactivator Proteins | 1 | 2002 | 79 | 0.220 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2002 | 94 | 0.220 |
Why?
|
| Rats | 14 | 2009 | 24260 | 0.210 |
Why?
|
| Polymers | 3 | 2006 | 1621 | 0.210 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1992 | 150 | 0.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2003 | 528 | 0.190 |
Why?
|
| Complement Activation | 1 | 2002 | 453 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2020 | 70 | 0.190 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3798 | 0.190 |
Why?
|
| Guanidines | 1 | 2000 | 193 | 0.180 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 1525 | 0.180 |
Why?
|
| Microcirculation | 2 | 2002 | 1286 | 0.180 |
Why?
|
| Blood Flow Velocity | 2 | 2016 | 1423 | 0.170 |
Why?
|
| Stem Cells | 2 | 2012 | 3567 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2017 | 23403 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 595 | 0.170 |
Why?
|
| Extracellular Matrix | 3 | 1997 | 1741 | 0.160 |
Why?
|
| Gene Expression | 7 | 1997 | 7799 | 0.160 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1998 | 74 | 0.160 |
Why?
|
| Basement Membrane | 3 | 1994 | 356 | 0.150 |
Why?
|
| Aspirin | 2 | 2009 | 3282 | 0.150 |
Why?
|
| Glomerular Mesangium | 1 | 1997 | 108 | 0.150 |
Why?
|
| Rats, Inbred SHR | 1 | 1997 | 195 | 0.150 |
Why?
|
| Activin Receptors | 1 | 2017 | 43 | 0.150 |
Why?
|
| Neuroglia | 1 | 2003 | 927 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2007 | 4199 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2017 | 28 | 0.150 |
Why?
|
| Hypertension, Renal | 1 | 1997 | 177 | 0.150 |
Why?
|
| Azabicyclo Compounds | 1 | 2017 | 68 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 12072 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4751 | 0.140 |
Why?
|
| Animals | 21 | 2020 | 168757 | 0.130 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 694 | 0.130 |
Why?
|
| Blotting, Northern | 6 | 1998 | 1581 | 0.130 |
Why?
|
| Lymphokines | 1 | 1998 | 949 | 0.130 |
Why?
|
| Cells, Cultured | 9 | 2012 | 19229 | 0.120 |
Why?
|
| bcl-X Protein | 3 | 2001 | 411 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 617 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 4554 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4420 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2002 | 1373 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 2015 | 0.110 |
Why?
|
| von Willebrand Factor | 2 | 1994 | 669 | 0.110 |
Why?
|
| Diabetic Angiopathies | 2 | 2001 | 818 | 0.110 |
Why?
|
| RNA | 4 | 2009 | 2749 | 0.110 |
Why?
|
| Perfusion | 1 | 2016 | 1360 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 1997 | 1364 | 0.100 |
Why?
|
| Male | 24 | 2017 | 350118 | 0.100 |
Why?
|
| Choroidal Neovascularization | 1 | 2014 | 343 | 0.100 |
Why?
|
| Actins | 5 | 1997 | 2121 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 821 | 0.090 |
Why?
|
| Prosencephalon | 1 | 1992 | 303 | 0.090 |
Why?
|
| Umbilical Veins | 3 | 1997 | 433 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2002 | 295 | 0.090 |
Why?
|
| Arterioles | 1 | 2010 | 254 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 1992 | 574 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 849 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2000 | 643 | 0.080 |
Why?
|
| Integrins | 1 | 1993 | 846 | 0.080 |
Why?
|
| Cell Division | 4 | 1997 | 4568 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 1996 | 1359 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2006 | 4217 | 0.080 |
Why?
|
| Middle Aged | 16 | 2016 | 213383 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2016 | 8554 | 0.080 |
Why?
|
| Galactose | 2 | 2000 | 306 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 1991 | 1472 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2010 | 597 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1992 | 1213 | 0.070 |
Why?
|
| Imidazoles | 2 | 2004 | 1206 | 0.070 |
Why?
|
| Thrombosis | 1 | 2001 | 2968 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 2014 | 980 | 0.070 |
Why?
|
| Humans | 34 | 2016 | 744343 | 0.070 |
Why?
|
| Cadaver | 2 | 2001 | 1337 | 0.070 |
Why?
|
| DNA Primers | 3 | 1996 | 2892 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 1998 | 6171 | 0.070 |
Why?
|
| Blood Vessels | 1 | 1992 | 1125 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2000 | 18111 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4669 | 0.070 |
Why?
|
| Cysts | 1 | 2011 | 678 | 0.070 |
Why?
|
| Hypertonic Solutions | 2 | 1995 | 93 | 0.070 |
Why?
|
| Female | 19 | 2016 | 380194 | 0.070 |
Why?
|
| Young Adult | 4 | 2016 | 56430 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14557 | 0.060 |
Why?
|
| Time Factors | 4 | 2017 | 40075 | 0.060 |
Why?
|
| Retinal Diseases | 1 | 2011 | 683 | 0.060 |
Why?
|
| Aged | 15 | 2014 | 163280 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 2038 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2282 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 1990 | 1017 | 0.060 |
Why?
|
| Complement Pathway, Classical | 1 | 2002 | 97 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 1950 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2005 | 600 | 0.050 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2002 | 112 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2002 | 46 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1155 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1998 | 1801 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2017 | 6256 | 0.050 |
Why?
|
| RNA Probes | 2 | 1992 | 113 | 0.050 |
Why?
|
| Reference Values | 2 | 2002 | 4982 | 0.050 |
Why?
|
| Receptors, Somatomedin | 1 | 2001 | 57 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 2 | 2011 | 2657 | 0.050 |
Why?
|
| Indomethacin | 1 | 2001 | 332 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2187 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 225 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2000 | 5179 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2001 | 122 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2000 | 11366 | 0.050 |
Why?
|
| Adult | 7 | 2016 | 214055 | 0.050 |
Why?
|
| Complement C3 | 1 | 2002 | 461 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2001 | 380 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1375 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 293 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2001 | 236 | 0.050 |
Why?
|
| Annexin A5 | 1 | 2000 | 103 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2005 | 899 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2001 | 8436 | 0.040 |
Why?
|
| Transcription, Genetic | 4 | 1998 | 7722 | 0.040 |
Why?
|
| Mice | 3 | 2020 | 81183 | 0.040 |
Why?
|
| Heart Rate | 1 | 2010 | 4091 | 0.040 |
Why?
|
| Factor VIII | 1 | 2001 | 347 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2014 | 546 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 1997 | 3144 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19905 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2327 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2001 | 705 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2635 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3086 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 1997 | 92 | 0.040 |
Why?
|
| Vinculin | 1 | 1997 | 62 | 0.040 |
Why?
|
| Immune Sera | 1 | 1998 | 641 | 0.040 |
Why?
|
| Rats, Inbred WKY | 1 | 1997 | 158 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1997 | 112 | 0.040 |
Why?
|
| Alloxan | 1 | 1996 | 13 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 428 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 772 | 0.040 |
Why?
|
| Densitometry | 1 | 1996 | 156 | 0.030 |
Why?
|
| Animal Feed | 1 | 1996 | 110 | 0.030 |
Why?
|
| Chickens | 1 | 1998 | 865 | 0.030 |
Why?
|
| Poly A | 2 | 1993 | 185 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2008 | 4026 | 0.030 |
Why?
|
| Amiloride | 1 | 1995 | 121 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2001 | 3128 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 3508 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2508 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 554 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1998 | 1682 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 537 | 0.030 |
Why?
|
| Receptors, Laminin | 1 | 1993 | 26 | 0.030 |
Why?
|
| Receptors, Fibronectin | 1 | 1993 | 39 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2012 | 21746 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6314 | 0.030 |
Why?
|
| Base Sequence | 2 | 1996 | 12797 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4740 | 0.030 |
Why?
|
| Trypsin | 1 | 1994 | 511 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2014 | 344 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2005 | 3068 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9438 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1799 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 657 | 0.030 |
Why?
|
| Reference Standards | 1 | 1996 | 1025 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 464 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1992 | 138 | 0.030 |
Why?
|
| Diuretics | 1 | 1995 | 592 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 2503 | 0.030 |
Why?
|
| Cattle | 1 | 1998 | 3922 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1992 | 878 | 0.030 |
Why?
|
| Pregnancy in Diabetics | 1 | 1993 | 179 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1991 | 102 | 0.030 |
Why?
|
| Laminin | 1 | 1993 | 419 | 0.030 |
Why?
|
| Cause of Death | 1 | 2002 | 3584 | 0.030 |
Why?
|
| Plasminogen Inactivators | 1 | 1991 | 38 | 0.030 |
Why?
|
| DNA Probes | 1 | 1992 | 560 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 53288 | 0.020 |
Why?
|
| Rabbits | 1 | 1998 | 4894 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1085 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1991 | 122 | 0.020 |
Why?
|
| Cell Death | 1 | 1996 | 1706 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 1992 | 399 | 0.020 |
Why?
|
| Cell Survival | 1 | 2000 | 5882 | 0.020 |
Why?
|
| Acetylcholine | 1 | 1992 | 621 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 25625 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1992 | 813 | 0.020 |
Why?
|
| Sodium | 1 | 1995 | 1623 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 2505 | 0.020 |
Why?
|
| Aorta | 1 | 1997 | 2061 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 10638 | 0.020 |
Why?
|
| Genes | 1 | 1992 | 1893 | 0.020 |
Why?
|
| Tissue Donors | 1 | 1998 | 2240 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1991 | 2255 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1993 | 707 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 1995 | 984 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 2839 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2649 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3870 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 4320 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1991 | 1227 | 0.020 |
Why?
|
| Exons | 1 | 1992 | 2437 | 0.020 |
Why?
|
| Neurons | 1 | 2005 | 9338 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8428 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 10943 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1991 | 1261 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 1992 | 2012 | 0.020 |
Why?
|
| Prevalence | 1 | 2001 | 15226 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1991 | 1640 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5974 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 6473 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 85781 | 0.010 |
Why?
|
| Aging | 1 | 2001 | 8664 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 9274 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 18370 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 2263 | 0.010 |
Why?
|
| Cytokines | 1 | 2014 | 7322 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 21683 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 11124 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 7301 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 18029 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 11725 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4409 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1998 | 40561 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1993 | 70 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1701 | 0.000 |
Why?
|
| Gestational Age | 1 | 1993 | 3493 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 77449 | 0.000 |
Why?
|
| Pregnancy | 1 | 1993 | 29144 | 0.000 |
Why?
|